Home » St. Jude Lands E.U. Win for Next-Gen Multi-Point Defibrillator

St. Jude Lands E.U. Win for Next-Gen Multi-Point Defibrillator

June 24, 2013

St. Jude has won the EU’s CE Mark for its Quadra Assura MP defibrillator. The company says that the device allows physicians to better monitor the function of the left side of the heart.
MassDevice

08Feb
Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions
09Feb
The Inextricable Link Between Data Integrity and Quality Culture
15Feb
Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis
16Feb
Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success
22Feb
Best Practices for Developing and Maintaining a GxP Training Matrix
07Mar
FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

St. Jude Lands E.U. Win for Next-Gen Multi-Point Defibrillator

Upcoming Events

Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

The Inextricable Link Between Data Integrity and Quality Culture

Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

Best Practices for Developing and Maintaining a GxP Training Matrix

FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

FDA Issues Update on LivaNova Recall of Blood Pumping System

EU Expands Dupixent’s Authorization to Include Eosinophilic Esophagitis

MedTrace Receives U.S. Patent for Heart Modeling Method

NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures

The Revised ICH E8: A Guide to New Clinical Trial Requirements